CClinicalTrials.gg
Status unknownNCT05138744Updated Dec 1, 2021

Behavioral Activation for Depression Through Virtual Reality

An interventional study of Behavioral activation using virtual reality in Depression, sponsored by Universitat Jaume I. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-01.

Sponsored by Universitat Jaume I · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Evaluate the effectiveness of a brief, virtual reality intervention for depressed mood

02

Conditions studied

03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 8 is below the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Universitat Jaume I is the lead sponsor of 79 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient Health Questionnaire - 9 (measure of depression) over 9
  • Positive and Negative Affect Schedule (measure of positive and negative affect): positive affect score below 24
  • Age over 18 years
  • Signs informed consent

Exclusion criteria

Exclusion Criteria:

  • Completes more than 20% of evaluations retrospectively (not the day they are assigned)
  • Has a severe mental health disorder as evaluated with the MINI International Neuropsychiatric Interview
  • Does not sign the informed consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (estimated)

Study arms

  • Experimental
    Virtual reality treatment

    Use of google maps with virtual reality to virtually situate the participants into scenarios that are motivating for them (i.e., the beach, a mountain, a park, etc.) at their choice.

    Other: Behavioral activation using virtual reality

Interventions

  • OtherBehavioral activation using virtual reality

    The investigators will encourage behavioral activation (increase in the number and time of conducted activities) situating the person in motivating situations using virtual reality

06

What researchers measure

Primary outcomes

  1. Change in Behavioral activation

    In a scale from 0 (not at all) to 6 (completely), "to what extent were you satisfied with what you did today?"

    Time frame: Change through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline vs posttreatment)

Secondary outcomes

  1. Change in Mood

    In a scale from 0 (completely sad) to 100 (completely happy), "how did you feel today?"

    Time frame: Change through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

  2. Change in Depression

    In a scale from 0 (not at all) to 3 (completely), "how was your level of depression today?"

    Time frame: Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

  3. Change in Positive affect

    In a scale from 1 (not at all) to 5 (completely), "how was your positive affect today?"

    Time frame: Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

  4. Change in Negative affect

    In a scale from 1 (not at all) to 5 (completely), "how was your negative affect today?"

    Time frame: Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

  5. Change in Activity level

    In a scale from 0 (minimum) to 100 (maximum), "what was your activity level today?"

    Time frame: Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Data will be anonymized and will only be shared upon reasonable request without identifying information

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 1, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05138744
Lead sponsor
Universitat Jaume I
Responsible party
Sponsor
First posted
Dec 1, 2021
Start date
Dec 5, 2021 (estimated)
Primary completion
Jan 22, 2022 (estimated)
Completion
Feb 20, 2022 (estimated)
Last update
Dec 1, 2021

Study contacts

Desirée Colombo, PhD
Contact
dcolombo@uji.es
964 387648
Carlos Suso, PhD
Contact
susor@uji.es

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion